Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $1.13 billion. The enterprise value is $254.01 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GPCR has 57.34 million shares outstanding. The number of shares has increased by 43.31% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 57.34M |
| Shares Change (YoY) | +43.31% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 5.80% |
| Owned by Institutions (%) | 104.40% |
| Float | 49.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.74, with a Debt / Equity ratio of 0.00.
| Current Ratio | 24.74 |
| Quick Ratio | 24.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -18.60% and return on invested capital (ROIC) is -14.90%.
| Return on Equity (ROE) | -18.60% |
| Return on Assets (ROA) | -14.28% |
| Return on Invested Capital (ROIC) | -14.90% |
| Return on Capital Employed (ROCE) | -18.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$751,693 |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $310,000 in taxes.
| Income Tax | 310,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.93% in the last 52 weeks. The beta is -2.52, so GPCR's price volatility has been lower than the market average.
| Beta (5Y) | -2.52 |
| 52-Week Price Change | -53.93% |
| 50-Day Moving Average | 24.24 |
| 200-Day Moving Average | 33.94 |
| Relative Strength Index (RSI) | 38.79 |
| Average Volume (20 Days) | 746,118 |
Short Selling Information
| Short Interest | 7.04M |
| Short Previous Month | 6.92M |
| Short % of Shares Out | 12.28% |
| Short % of Float | 14.18% |
| Short Ratio (days to cover) | 8.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -158.23M |
| Pretax Income | -100.26M |
| Net Income | -122.53M |
| EBITDA | -157.23M |
| EBIT | -158.23M |
| Earnings Per Share (EPS) | -$2.33 |
Full Income StatementBalance Sheet
The company has $883.52 million in cash and $3.86 million in debt, giving a net cash position of $879.66 million or $15.34 per share.
| Cash & Cash Equivalents | 883.52M |
| Total Debt | 3.86M |
| Net Cash | 879.66M |
| Net Cash Per Share | $15.34 |
| Equity (Book Value) | 864.84M |
| Book Value Per Share | 15.10 |
| Working Capital | 855.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$116.64 million and capital expenditures -$1.29 million, giving a free cash flow of -$117.93 million.
| Operating Cash Flow | -116.64M |
| Capital Expenditures | -1.29M |
| Free Cash Flow | -117.93M |
| FCF Per Share | -$2.06 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |